Engineering mtDNA deletions by reconstituting end joining in human mitochondria
Authors:
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Cancer Institute (R35CA283988)
- National Institute on Aging (R01AG085782)
- Howard Hughes Medical Institute
- Damon Runyon Cancer Research Foundation (DRG-2521-24)
- G. Harold and Leila Y. Mathers Charitable Foundation
- Pew Charitable Trusts
- National Institute of General Medical Sciences (R35GM147191)
- National Institute of General Medical Sciences (P30CA008748)
- Edward Mallinckrodt, Jr. Foundation
- National Institutes of Health
This publication has 93 references indexed in Scilit:
- Mitochondrial DNA copy number in human disease: the more the better?FEBS Letters, 2020
- Recovering Gene Interactions from Single-Cell Data Using Data DiffusionCell, 2018
- An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate SynthesisCell, 2015
- Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating CellsCell, 2015
- Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large‐scale deletions or point mutationsEMBO Molecular Medicine, 2014
- Induced Pluripotent Stem Cells with a Mitochondrial DNA DeletionStem Cells, 2013
- Human Induced Pluripotent Stem Cells Harbor Homoplasmic and Heteroplasmic Mitochondrial DNA Mutations While Maintaining Human Embryonic Stem Cell–like Metabolic ReprogrammingStem Cells, 2011
- Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletionsJournal of Human Genetics, 2008
- Nonviability of cells with oxidative defects in galactose medium: A screening test for affected patient fibroblastsBiochemical Medicine and Metabolic Biology, 1992
- Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNAAnnals of Neurology, 1989